CARAMBA consortium partner Myeloma Patients Europe (MPE) has issued an information sheet about the CARAMBA clinical trial which will take place in four centres of excellence in myeloma clinical care and research: University Hospital Würzburg (Germany), Ospedale San Raffaele (Italy), Universidad de Navarra (Spain) and the Centre Hospitalier Regional et Universitaire de Lille (France).
To inform patients and caregivers, the information sheet by Myeloma Patients Europe explains the main goals and characteristics of this clinical trial and possible CAR-T side effects to consider.
The Information sheet is also available in French, Italian, Spanish and German (Please see here).
It is the first contribution in a new publications series by Myeloma Patients Europe called “myeloma pipeline.” These documents aim at providing patients with information about myeloma treatments currently being investigated in clinical trials.
